Skip to main content
. Author manuscript; available in PMC: 2024 Mar 4.
Published in final edited form as: J Clin Pathol. 2021 Jul 26;76(1):34–39. doi: 10.1136/jclinpath-2021-207702

Table 1.

Clinicopathological characteristics of colorectal carcinoma patients

N=348 NR (N=38) NI (N=43) NP (N=267) P value
Age (years) 68.97±14.95 67.26±12.64 63.95±14.17 0.0625
Sex 0.7167
 Male 16 (42.11%) 22 (51.16%) 126 (47.19%)
 Female 22 (57.89%) 21 (48.84%) 141 (52.81%)
Histological grade 0.0222
 Low 21 (55.26%) 34 (79.07%) 201 (75.28%)
 High 17 (44.74%) 9 (20.93%)  66 (24.72%)
Tumour location 0.0025
 Left 1 1 (28.95%) 26 (60.47%) 155 (58.05%)
 Right 27 (71.05%) 17 (39.53%) 112 (41.95%)
TNM stage 0.0346
 I 2 (5.26%) 1 1 (25.58%) 57 (21.35%)
 II 16 (42.11%) 9 (20.93%) 100 (37.45%)
 III 19 (50%) 22 (51.16%) 94 (35.21%)
 IV 1 (2.63%) 1 (2.33%) 16 (5.99%)
MMR status 0.0027
 Proficient 20 (52.63%) 34 (79.07%) 208 (77.90%)
 Deficient 18 (47.37%) 9 (20.93%% 59 (22.10%)

MMR, mismatch repair; NI, neutrophil-intermediate; NP, neutrophil-poor; NR, neutrophil-rich; TNM, tumour, node, metastasis.